Functional characterization of the carnitine transporter defective in primary carnitine deficiency

Arch Biochem Biophys. 1999 Apr 1;364(1):99-106. doi: 10.1006/abbi.1999.1118.

Abstract

Primary carnitine deficiency is an autosomal recessive disorder caused by defective carnitine transport which impairs fatty acid oxidation and manifests as nonketotic hypoglycemia or skeletal or heart myopathy. Here we report the functional characterization of this transporter in human fibroblasts. Carnitine enters normal cells by saturable and unsaturable routes, the latter corresponding to Na+-independent uptake. Saturable carnitine transport was absent in cells from patients with primary carnitine deficiency. In control cells, saturable carnitine transport was energized by the electrochemical gradient of Na+. Carnitine uptake was not inhibited by amino acid substrates of transport systems A, ASC, and X-AG, but was inhibited competitively (in potency order) by butyrobetaine > carnitine > palmitoylcarnitine = acetylcarnitine > betaine. Carnitine uptake was also noncompetitively inhibited by verapamil and quinidine, inhibitors of the multidrug resistance family of membrane transporters, suggesting that the carnitine transporter may share a functional motif with this class of transporters. A high-affinity carnitine transporter was present in kidney 293 cells, but not in HepG2 liver cells, whose carnitine transporter had a Km in the millimolar range. These result indicate the presence of multiple types of carnitine transporters in human cells.

MeSH terms

  • Acetylcarnitine / pharmacology
  • Anti-Arrhythmia Agents / pharmacology
  • Betaine / analogs & derivatives
  • Betaine / pharmacology
  • Binding, Competitive / drug effects
  • Biological Transport / drug effects
  • Carnitine / deficiency*
  • Carnitine / metabolism*
  • Carrier Proteins / antagonists & inhibitors
  • Carrier Proteins / metabolism*
  • Carrier Proteins / physiology*
  • Cells, Cultured
  • Fibroblasts / metabolism
  • Humans
  • Kidney / metabolism
  • Liver / metabolism
  • Membrane Potentials / drug effects
  • Organic Cation Transport Proteins*
  • Palmitoylcarnitine / pharmacology
  • Potassium / metabolism
  • Sodium / metabolism
  • Solute Carrier Family 22 Member 5

Substances

  • Anti-Arrhythmia Agents
  • Carrier Proteins
  • Organic Cation Transport Proteins
  • SLC22A5 protein, human
  • Solute Carrier Family 22 Member 5
  • Palmitoylcarnitine
  • Betaine
  • gamma-butyrobetaine
  • Acetylcarnitine
  • Sodium
  • Potassium
  • Carnitine